Feb. 16, 2006 — The US Food and Drug Administration (FDA) and Bayer Pharmaceuticals Corporation have warned healthcare professionals against inadvertent parenteral administration of contents from ...
NIMOTOP (nimodipine) is a calcium channel blocker indicated for patients with subarachnoid hemorrhage. It improves neurological outcome by relaxing cerebral smooth muscle vasculature and preventing ...